Home

Shnilý Zasnoubený týdně roma index tumor marker Věčné Obrození Tání

SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy  algorithm (ROMA), and risk malignancy index (RMI) for the classification of  ovarian masses A comparison of CA125, HE4, risk ovarian
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian

Analysis of falsely elevated risk of ovarian malignancy algorithm in women  with ovarian endometrioma
Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma

He4 and Risk for Ovarian Cancer Algorithm - Dr Lal PathLabs
He4 and Risk for Ovarian Cancer Algorithm - Dr Lal PathLabs

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis.  - Document - Gale Academic OneFile
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile

Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for  Preoperative Assessment of Adnexal Tumors
Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors

CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline  Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

ROMA (Risk of Ovarian Malignancy Algorithm)
ROMA (Risk of Ovarian Malignancy Algorithm)

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian  cancer
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer

Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and...  | Download Table
Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and... | Download Table

RMI and ROMA are equally effective in discriminating between benign and  malignant gynecological tumors: A prospective population‐based study -  Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online  Library
RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library

HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125  Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete  Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis

Reference intervals of HE4 and ROMA value according to age groups |  Download Table
Reference intervals of HE4 and ROMA value according to age groups | Download Table

Diagnostics | Free Full-Text | The Comparison of Three Predictive Indexes  to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma:  The Characteristics and Efficacy
Diagnostics | Free Full-Text | The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy

SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy  algorithm (ROMA), and risk malignancy index (RMI) for the classification of  ovarian masses A comparison of CA125, HE4, risk ovarian
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian

Ovarian masses: Surgery or surveillance? | MDedge ObGyn
Ovarian masses: Surgery or surveillance? | MDedge ObGyn

Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and  risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models  with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms

JGO :: Journal of Gynecologic Oncology
JGO :: Journal of Gynecologic Oncology

Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125  to discriminate between benign ovarian tumor and early‑stage ovarian cancer  according to imaging tumor subtypes
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes

The receiver operating characteristic of risk of ovarian malignancy... |  Download Scientific Diagram
The receiver operating characteristic of risk of ovarian malignancy... | Download Scientific Diagram

Diagnostic Values of HE4, CA125, RMI and ROMA using Standard and... |  Download Table
Diagnostic Values of HE4, CA125, RMI and ROMA using Standard and... | Download Table

Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis -  ScienceDirect
Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis - ScienceDirect

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and  risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models  with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms

Diagnostic measures comparison for ovarian malignancy risk in Epithelial  ovarian cancer patients: a meta-analysis | Scientific Reports
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports